What's happened
The FDA has approved bemotrizinol (BEMT) for over‑the‑counter sunscreens, marking a modernization in U.S. UV protection. The ingredient absorbs both UVA and UVB rays, is photostable, and will debut as Parsol Shield before broader market adoption after an 18‑month exclusivity period. Industry and dermatology experts say the move could improve protection and user experience, though rollout and formulation timelines remain.
What's behind the headline?
Context and implications
- Bemotrizinol marks the first major update to U.S. sunscreen ingredients in years. This aligns U.S. standards with many international markets, which have long offered broader UVA/UVB protection.
- Experts expect bemotrizinol to offer better UVA coverage and a smoother cosmetic feel, potentially reducing white cast and irritation associated with some chemical filters.
- The regulatory framework shift was expedited by a 2020 Congress authorization that streamlined reviews, setting a precedent for future ingredient introductions.
- In practice, consumers should anticipate a lag between approval and grocery-store availability as brands reformulate products and clear supply chains.
Forecast
- The move will likely drive faster innovation in sunscreen formulas and may push other filters toward U.S. approval.
- Access to bemotrizinol could improve protection for sensitive skin and encourage higher adoption of broader spectrum products.
- Compliance timelines and cost considerations will shape how quickly consumers notice benefits.
How we got here
The FDA has approved bemotrizinol (BEMT) for use in over‑the‑counter sunscreens, ending decades of slower reform. Bemotrizinol is widely used in Europe and Asia, offering broad spectrum protection with good skin compatibility. It will launch in the U.S. under Parsol Shield by DSM Nutritional Products, with other manufacturers gaining access after 18 months.
Our analysis
New York Times Business, Axios, Business Insider UK, AP News, Independent Business, New York Post Business; coverage across outlets highlights the EU/Asia precedent, FDA process changes, and cosmetic performance considerations.
Go deeper
- Will bemotrizinol become the standard in most U.S. sunscreens within the next year?
- How will reformulations affect price and product availability?
- What should consumers look for on labels regarding UVA/UVB protection?
More on these topics
-
bemotrizinol - Compounds
Bemotrizinol is an oil-soluble organic compound that is added to sunscreens to absorb UV rays. It is marketed as Parsol Shield, Tinosorb S, and Escalol S. Bemotrizinol is a broad-spectrum UV absorber, absorbing UVB as well as UVA rays. It has two absorpti
-
United States - Country in North America
The United States of America, commonly known as the United States or America, is a country mostly located in central North America, between Canada and Mexico.
-
Environmental Working Group - Corporation
The Environmental Working Group is an American activist group that specializes in research and advocacy in the areas of agricultural subsidies, toxic chemicals, drinking water pollutants, and corporate accountability. EWG is a nonprofit organization.
-
Europe - Region in Europe
Central Europe is the region comprising the central part of Europe. Central Europe occupies continuous territories that are otherwise sometimes considered parts of Western Europe, Southern Europe and Eastern Europe.
-
Sunscreen Lotion - Medication
Sunscreen, also known as sunblock, is a lotion, spray, gel, foam, stick or other topical product that absorbs or reflects some of the sun's ultraviolet radiation and thus helps protect against sunburn.